Article ID Journal Published Year Pages File Type
8922431 Clinical and Translational Radiation Oncology 2018 7 Pages PDF
Abstract
Early clinical outcomes reports suggest that the combination of ipilimumab and RT may improve survival in metastatic melanoma patients. The abscopal responses become a clinically relevant effect of such combination and should be studied in controlled randomized trials.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , ,